Kapil Dhingra - Director at Replimune Group, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
REPL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Kapil Dhingra since 12/3/2023

Holdings reported by Kapil Dhingra for Replimune Group, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (right to buy) 32K Apr 1, 2024 Direct Common Stock

Transactions reported by Kapil Dhingra for Replimune Group, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.